CAS 51350-19-7
:(2S,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Description:
The chemical substance known as (2S,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol, with the CAS number 51350-19-7, is a purine derivative that features a nonan-2-ol backbone. This compound is characterized by the presence of a purine ring, which is a fundamental structure in nucleic acids, and an amino group that contributes to its biological activity. The stereochemistry indicated by (2S,3S) suggests specific spatial arrangements of the hydroxyl and amino groups, which can influence the compound's interactions and reactivity. Typically, such compounds may exhibit properties relevant to biological systems, potentially acting as nucleoside analogs or influencing metabolic pathways. The presence of the hydroxyl group indicates that it may participate in hydrogen bonding, affecting solubility and reactivity. Overall, this compound's unique structure positions it as a candidate for further research in medicinal chemistry and biochemistry, particularly in the context of nucleic acid metabolism and therapeutic applications.
Formula:C14H23N5O
InChI:InChI=1/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11-/m0/s1
SMILES:CCCCCC[C@@H]([C@H](C)O)n1cnc2c(N)ncnc12
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
EHNA
CAS:EHNA is a potent and selective dual inhibitor of cyclic nucleotide phosphodiesterase 2 (PDE2) (IC50 = 4 μM) and adenosine deaminase (ADA). It exhibits concentration-dependent inhibition of cGMP-stimulated PDE2 activity, with IC50 values of 0.8 μM in humans and 2 μM in porcine myocardium, but shows limited inhibition on unstimulated PDE2. EHNA is involved in modulating various pharmacological responses, such as antiviral, antitumor, and antiarrhythmic effects.Formula:C14H23N5OColor and Shape:SolidMolecular weight:277.37
